Humors Tech Secures Funding for Breath-Based Health Screening Device

Humors Tech, a rising healthtech startup, has secured Rs 2 crore in a pre-seed funding round led by Venture Catalysts. This investment will fuel the commercial launch of Respyr, their flagship product, alongside vital clinical validation studies and a strategic push towards global markets.

Respyr: Revolutionizing Early Disease Detection

Respyr is a breath-based health screening device designed to revolutionize early detection and routine monitoring of a wide range of chronic conditions. This innovative tool has the potential to identify critical lifestyle disorders like diabetes, hypertension, heart disease, liver problems, kidney issues, and respiratory illnesses.

A Multi-Faceted Approach to Healthcare

Humors Tech embraces a dual B2B and B2B2C model, ensuring accessibility for a diverse range of stakeholders. Corporate entities, insurance providers, government hospitals, remote healthcare facilities, and individual consumers can all benefit from Respyr’s capabilities.

Beyond Screening: A Gateway to Better Health

Respyr offers a multitude of applications. It can be integrated with fitness apps and wearables, providing users with advanced health tracking capabilities. Additionally, Respyr serves as a valuable entry point for telemedicine platforms, potentially routing users for timely medical interventions based on their screening results.

Employee Wellness, Insurance Engagement, and Broader Healthcare Access

The applications of Respyr extend beyond individual health monitoring. It presents valuable opportunities for employee wellness programs within corporations, fostering a proactive approach to employee health. Insurance companies can leverage Respyr to enhance engagement and potentially improve risk assessment. Furthermore, Respyr’s capabilities hold immense promise for expediting medical screening processes and increasing access to healthcare services in remote areas.

Targeting a Widespread Market

Humors Tech aspires to reach a total addressable market (TAM) of 612 million individuals in India. Initially, they will focus on a serviceable available market (SAM) of 163 million health-conscious individuals, aiming to make preventive healthcare more accessible and empowering individuals to take charge of their well-being.